Get the Daily Report
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.Sign up
Subscribe
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today. Subscribe
The Giving Guide
This annual publication gives local nonprofits the opportunity to showcase their organizations and differentiate their mission and work so that businesses can make informed decisions on how to contribute.See Digital Edition
CeQur, Medtronic, Roche, and Biocorp made moves in the diabetes market.
CeQur has raised $115 million in an oversubscribed equity financing. The Lucerne, Switzerland-based company has developed CeQur Simplicity, a wearable insulin delivery system.
Credit Suisse Entrepreneur Capital Ltd. and Endeavour Vision led the financing with significant participation from new investors, including Tandem Diabetes Care, Ypsomed Group, Federated Hermes Kaufmann Funds, Kingdon Capital, and GMS Capital, as well as existing investors, Schroder & Co. Bank SA, and VI Partners.
Proceeds from the financing will be used to advance commercial plans for CeQur Simplicity, including market development activities, a phased commercial launch strategy that includes a limited market release in 2021, and the scale-up of high-volume manufacturing.
Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe